| Iopamidol - Wikipedia, the free encyclopedia Iopamidol (INN, tradenames Iopamiro, Isovue, Iopamiron, and Niopam) is a nonionic, low-osmolar iodinated contrast agent, developed by Bracco. It is available in ... Read More |
| Iopamidol Drug Information, Professional - Drugs.com ... Iopamidol Drug Information from Drugs.com. Includes Iopamidol side effects, interactions and indications. Read More |
| iopamidol medical facts from Drugs.com Physician reviewed iopamidol patient information - includes iopamidol description, dosage and directions. Read More |
| Iopamidol-370, Isovue-300, Isovue-370 (iopamidol) Drug Side ... Drug information on Iopamidol-370, Isovue-300, Isovue-370 (iopamidol), includes drug pictures, side effects, drug interactions, directions for use, symptoms of ... Read More |
| iopamidol - MSN Health - Medications Iopamidol is in a group of drugs called radiopaque RAY dee oh payk contrast agents. Iopamidol contains iodine a substance that absorbs x-rays. Radi Read More |
| Hovione - Iopamidol Home Page Hovione is the World ' s leading producer of generic contrast media agents. We are the largest producer of these compounds offering bulk product to ... Read More |
| iopamidol: Definition from Answers.com Iopamidol Brand names: Isovue®-200, Isovue®-250, Isovue®-300, Isovue®-370, Isovue-M® 200, Isovue-M® 300 Drug Forms: Iopamidol injection ... Read More |
| Iopamidol DESCRIPTION. Isovue-200/300/370. Isovue (Iopamidol Injection) formulations are stable, aqueous, sterile, and nonpyrogenic solutions for intravascular administration. Read More |
| Iopamidol - Side Effects, Dosage, Interactions - Drugs ... Iopamidol - Iopamidol is in a group of drugs called radiopaque (RAY dee oh payk) contrast agents. Iopamidol contains iodine, a substance that absorbs x-rays. Read More |
| Iopamidol - KidsHealth - the Web's most visited site about ... Is it safe for my child to take this drug? Not if your child has an allergy to iopamidol or any other part of this drug. If your child has contrast dye allergy, talk ... Read More |
